Clinical Trial Update: Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS). [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating deucravacitinib versus placebo for hidradenitis suppurativa has been terminated; no efficacy or safety results are provided in this u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Sotyktu (Deucravacitinib)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: TERMINATED